1. Introduction {#s0005}
===============

Lung cancer has become the most common cause of cancer-related death in both men and women, accounting for 28% of all cancer-related deaths in the U.S. ([@b0020]). Although treatment of lung cancer has improved, mortality remains high in lung cancer patients. A growing body of research suggests that naturally occurring compounds can act as antioxidants as well as cancer preventative and therapeutic agents ([@b0120; @b0125; @b0055]). Development of chemotherapeutic agents with maximal anti-tumor activity and minimal toxicity has become a favorable route for cancer management. In this context, mushrooms play a pivotal role as anti-tumor agents. Edible mushrooms have been used as health nutritional supplements for several centuries, and they complement chemotherapy and radiation therapy by countering the side effects of cancer ([@b0085]).

The bioactive compounds in mushrooms responsible for their anti-tumor potential include polysaccharides, proteins, fats, ash, glycosides, alkaloids, volatile oils, tocopherols, phenolics, flavonoids, carotenoids, folates, ascorbic acid enzymes, and organic acids ([@b0085; @b0090; @b0065; @b0040]). Among these bioactive compounds, polysaccharides are the most well-known and most potent mushroom-derived substances with anti-tumor activity ([@b0045]). In this study, we analyzed the anti-tumor activity of a polysaccharide (MFKF-AP1β) isolated from fruiting bodies of the medicinal mushroom *Fomes fomentarius* in human lung cancer A549 cells.

*F. fomentarius*, a basidiomycete fungus, has been used as a traditional Chinese and Korean medicine for many centuries for the treatment of various diseases, including oral ulcers, gastroenteric disorders, hepatocirrhosis, inflammation, and various cancers. Recent studies have shown that *F. fomentarius* has antioxidant, anti-inflammatory, and anti-diabetic activities ([@b0075; @b0115]). However, there are few reports on the apoptotic activity of *F. fomentarius* ([@b0060; @b0025]).

To discover novel agents from natural products that improve the therapeutic outcome of cancer, we tested the anti-tumor effects of a polysaccharide (MFKF-AP1β) isolated from *F. fomentarius* on A549 lung cancer cells. Specifically, we tested the apoptotic activity of MFKF-AP1β in lung carcinomas.

2. Materials and methods {#s0010}
========================

2.1. Reagents {#s0015}
-------------

RPMI 1640, HEPES, staurosporine, Hoechst 33342, and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide were purchased from Sigma--Aldrich, St. Louis, USA. Fetal bovine serum was supplied by Gibco, USA. All solvents were HPLC grade and supplied by J.T. Baker (Phillipsburg, NJ, USA).

2.2. Materials {#s0020}
--------------

Chemically water-extractable polysaccharide (MFKF-AP1β) was isolated from hot water extracts of fruiting bodies of mushroom *F. fomentarius* by successive DEAE-Sepharose FF and concanavalin A-Sepharose 4B column chromatography. Molecular weight of MFKF-AP1β was estimated to be about 12 kDa by high performance liquid chromatography (HPLC) ([@b0110]). Solutions of MFKF-AP1β (25--100 μg/ml) were prepared in a water/methanol mixture (1:1, v/v).

2.3. Cell culture {#s0025}
-----------------

Lung cancer cells A549 (KCLB) were cultivated in RPMI 1640 medium supplemented with 25 mM HEPES buffer, 25 mM sodium bicarbonate, 300 mM [l]{.smallcaps}-glutamate, and 10% heat-inactivated fetal bovine serum (Gibco, USA) in a CO~2~ incubator (5% CO~2~ in air) at 37 °C. For the experiment, cells were cultured in 12-well plates at 1 × 10^6^ cells/well. Cells were treated with several concentrations of MFKF-AP1β (25, 50, and 100 μg/ml) for 24 h. As a positive control, 1 μM staurosporine (Sigma, St. Louis, USA) was added for 4 h to induce apoptosis. Cells were then centrifuged (600*g* × 3 min) and harvested.

2.4. MTT assay and cell morphology {#s0030}
----------------------------------

Cell viability was measured by MTT bioassay. Briefly, A549 cells (1 × 10^6^ cells/well) were seeded in each well of a 96-well plate for 24 h. After incubation with different concentrations of MFKF-AP1β for 24 h, 10 μl of MTT solution (5 mg/ml on PBS) dissolved in PBS was added and incubated for 4 h. After color development, 100 μl of DMSO was applied. Absorbance was measured using an ELISA plate reader (Bio-Tek Instrument Co., WA, USA) at 540 nm. The viability% was measured using formula-$$\text{Sample\ absorbance}/\text{Control\ absorbance} \times 100\text{.}$$

2.5. Lactate dehydrogenase (LDH) assay {#s0035}
--------------------------------------

A549 cells (1 × 10^6^ cells/well) were seeded in each well of a 96-well plate for 24 h. After incubation with different concentrations of MFKF-AP1β for 24 h, medium was collected and cleared by centrifugation. After supernatants were collected, cytotoxicity was quantified by measuring the amount of total LDH released by cells using an LDH assay kit (Sigma--Aldrich, St. Louis, USA) according to the manufacturer's protocol. Briefly, LDH, a glycolytic enzyme, is concerned with the reduction of pyruvic acid in the presence of dihydronicotinamide adenine dinucleotide (NADH). LDH assay reagent was added to supernatants and incubated for up to 30 min at room temperature in the dark, after which the reaction was stopped by adding 1 N HCl. The absorbance of samples was measured at 450 nm.

2.6. Assay for nuclear apoptosis (Hoechst staining) {#s0040}
---------------------------------------------------

To determine DNA chromatin morphological features, cells were treated with Hoechst 33342 stain according to [@b0035]. Briefly, cells were cultured and treated for 24 h with different concentrations of MFKF-AP1β and staurosporine (1 μM) for 4 h. After washing twice in PBS, cells were fixed with cold 4% formaldehyde. Cells were then washed with PBS again and incubated with Hoechst 33342 (1 μg/ml) at 37 °C for 10 min. After washing with PBS, cells were analyzed under a fluorescence microscope (Nikon Eclipse TS100 Epi-fluorescence microscope, Japan).

2.7. Comet assay {#s0045}
----------------

To evaluate DNA damage, comet assay was performed according to [@b0140], with some modifications. A549 lung cancer cells treated with MFKF-AP1β and staurosporine were harvested by washing twice with phosphate-buffered saline (PBS) and then suspended in 70 μl of 1% (w/v) low melting point agarose in PBS, pH 7.4, at 37 °C. The cell solution was immediately pipetted onto frosted glass microscope slides pre-coated with a layer of 1% (w/v) normal melting point agarose, after which the third layer composed of 75 μl of 0.5% (w/v) low melting point agarose similarly prepared in PBS was applied. The agarose was allowed to set for 10 min on ice. To remove cellular proteins, slides were immersed in lysis solution (2.5 M NaCl, 0.1 M Na~2~EDTA, 10 mM Tris, pH 10.0, with NaOH, 10% v/v dimethyl sulfoxide, and 1% v/v Triton X-100) at 4 °C for 1 h. Slides were then placed in a electrophoresis tank containing electrophoresis buffer (0.3 M NaOH and 1 mM Na~2~EDTA) for 30 min before electrophoresis at 40 V for 40 min. The slides were then washed with neutralizing solution (0.4 M Tris--HCl, pH 7.5) for 20 min before staining with 50 μl of ethidium bromide (20 mg/ml), and analyzed visually with a Nikon EPI fluorescence microscope (Japan).

2.8. Measurement of single-stranded DNA {#s0050}
---------------------------------------

As DNA in apoptotic cells is sensitive to formamide, denatured DNA was detected by a monoclonal antibody against single-stranded DNA using an ApoStrand™ ELISA apoptosis detection kit (Enzo Life Sciences, Plymouth Meeting, PA, USA) according to the manufacturer's protocol. Briefly, 1.0 × 10^6^ cells were cultured in a 96-well microplate and treated with different concentrations of MFKF-AP1β. After 12 h, cells were fixed and dried for attachment to the plate surface. Cells were then treated with formamide and heated at 56 °C for 30 min, followed by incubation with an antibody mixture for 30 min after blocking non-specific binding sites. After washing, peroxidase substrate was added to each well, and the absorbance was measured at 405 nm using an ELISA reader (Bio-Tek Instrument Co., WA, USA).

2.9. Statistical analysis {#s0055}
-------------------------

Each experimental condition was analyzed at least in triplicate (*n* = 3). Data were expressed as the mean ± standard deviation (S.D.). Statistical analyses were carried out using Student's *t*-test. Differences were considered statistically significant at ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01, ^∗∗∗^*p* \< 0.001.

3. Results {#s0060}
==========

3.1. Anti-proliferative effects of MFKF-AP1β on A549 cells {#s0065}
----------------------------------------------------------

We characterized the anti-proliferative effects of MFKF-AP1β on A549 cells by measuring cell viability using MTT assay. Cultures of A549 cells were treated with MFKF-AP1β at concentrations of 25, 50, and 100 μg/ml for 24 h. As shown in [Fig. 1](#f0005){ref-type="fig"}, MFKF-AP1β inhibited proliferation of A549 cells. Cell viability was lowest (59.22 ± 5.17%) after 24 h of MFKF-AP1β treatment at a concentration of 100 μg/ml, as compared to MFKF-AP1β concentrations of 25 and 50 μg/ml (64.46 ± 1.48% and 65.73 ± 1.24%, respectively).

3.2. Cytotoxic effects of MFKF-AP1β {#s0070}
-----------------------------------

To better characterize the cytotoxicity of MFKF-AP1β in human lung cancer cells (A549), we performed cellular lactate dehydrogenase (LDH) release assay. In this experiment, intracellular LDH released into culture medium was an indicator of cytotoxicity. A549 cells treated with 25, 50, and 100 μg/ml of MFKF-AP1β for 24 h showed a dose-dependent increase in LDH activity, indicating cellular damage. Further, LDH release into culture medium was highest upon treatment with 100 μg/ml of MFKF-AP1β (43.74 ± 1.19%), which induced A549 cell death through cytotoxicity ([Fig. 2](#f0010){ref-type="fig"}). A significantly lower amount of LDH was released at concentrations of 25 and 50 μg/ml (39.91 ± 1.19% and 40.25 ± 1.29%, respectively).

3.3. MFKF-AP1β induces significant morphological alterations {#s0075}
------------------------------------------------------------

The cytotoxic effects of MFKF-AP1β were also reflected in the morphological appearance of A549 cells after 24 h ([Fig. 3](#f0015){ref-type="fig"}). Treatment with 1 μM staurosporine and 100 μg/ml of MFKF-AP1β had a marked effect on cellular morphology, as cells became more round and refractile under a microscope. Cells treated with 100 μg/ml of MFKF-AP1β became apoptotic bodies and eventually detached from the surface, whereas untreated cells (control) remained well spread with a flattened morphology. Treatment with 50 μg/ml of MFKF-AP1β had a comparatively weaker effect, and 25 μg/ml of MFKF-AP1β had no discernible effect. These results suggest that MFKF-AP1β-treated human lung cancer cells undergo cell death and exhibit morphological features suggestive of apoptosis.

3.4. MFKF-AP1β potentiates cellular apoptosis {#s0080}
---------------------------------------------

To determine whether or not the above results can be attributed to apoptosis of A549 cells, we performed chromatin condensation assay using Hoechst 33342 visualized by fluorescence microscopy. Hoechst staining assay ([Fig. 4](#f0020){ref-type="fig"}) revealed a greater number of apoptotic cells showing characteristic morphologic alterations such as nucleic shrinkage and formation of pycnonuclei following treatment with 100 μg/ml of MFKF-AP1β and staurosporine for 24 h compared to the control group.

3.5. MFKF-AP1β induces DNA fragmentation in A549 cells {#s0085}
------------------------------------------------------

Degradation of DNA into multiple internucleosomal fragments of 180--200 base pairs is a distinct biochemical hallmark of apoptosis. To detect this, we performed single cell gel electrophoresis (comet assay), which is a sensitive technique that allows detection of DNA strand breaks. Cells treated with staurosporine and MFKF-AP1β showed comet formation in a dose-dependent manner, whereas untreated cells did not show any comet-like appearance ([Fig. 5](#f0025){ref-type="fig"}). To further determine whether or not DNA fragmentation is typical of apoptosis, we performed apoptosis detection assay using an ApoStrand™ ELISA apoptosis detection kit, which detects *in vitro* single-stranded DNA breaks induced by MFKF-AP1β treatment. The sensitivity of this assay reflects changes in chromatin structure associated with apoptosis, such as chromatin condensation and digestion of proteins stabilizing DNA. As shown in [Fig. 6](#f0030){ref-type="fig"}, treatment with MFKF-AP1β at concentrations of 25, 50, and 100 μg/ml for 24 h significantly increased the apoptotic rate of A549 cells in a dose-dependent manner. Taken together, these results indicate that, apart from its cytotoxic effects, MFKF-AP1β can induce apoptosis in A549 cells.

4. Discussion {#s0090}
=============

Cancer remains one of the major causes of death worldwide. The most effective treatment strategy for cancer is cytotoxic agent-based chemotherapy, which increases patient survival but also has side effects that severely limit its clinical effectiveness such as acquisition of drug resistance ([@b0015; @b0135; @b0070]). Therefore, novel therapeutic strategies involving natural compounds could reduce the cumulative effects of chemotherapy by enhancing anti-tumor activities. The present paper evaluated the effects of MFKF-AP1β, a dietary polysaccharide from medicinal mushroom *F. fomentarius*, on a human lung adenocarcinoma cell line (A549) in relation to cell growth inhibition and apoptosis induction. The anti-tumor activities of polysaccharides isolated from medicinal fungi are very attractive due to their low toxicity in normal cells and their apparent lack of side effects in clinical patients ([@b0050]).

In this study, we first reported a cell growth inhibitory effect for MFKF-AP1β in lung cancer cells. Exposure to MFKF-AP1β for 24 h resulted in dose-dependent inhibition of A549 cell growth, as evidenced by cell morphological alterations ([Fig. 3](#f0015){ref-type="fig"}). Further, MFKF-AP1β reduced cellular metabolic activity of A549 cells and potentiated cytotoxic activity via LDH release into the medium ([Fig. 3](#f0015){ref-type="fig"}). Up to this point, the mode of cell death responsible for these results was unconfirmed. Autophagy, apoptosis, and necrosis are all different types of cell death, and apoptosis is the desired mode of cell death in chemotherapy ([@b0010]). Recently, studies have extensively focused on the apoptotic potential of compounds as anti-tumor agents ([@b0130]). In the current study, we investigated whether or not the cytotoxic effects of MFKF-AP1β on A549 cells were mediated via apoptosis by examining cellular changes associated with apoptosis using comet assay, Hoechst staining, and apoptosis assay.

Induction of apoptosis is a common mechanism of anti-tumor drugs ([@b0005]). Here, we detected apoptotic cells by comet assay with ethidium bromide staining as well as apoptosis assay, which detects formation of single-stranded DNA breaks ([Figs. 5 and 6](#f0025 f0030){ref-type="fig"}, respectively). MFKF-AP1β-treated cells exhibited a dose-dependent increase in nuclear chromatin staining, as visualized by Hoechst 33342 ([Fig. 4](#f0020){ref-type="fig"}), including morphological characteristics of apoptotic cells such as increased nuclear condensation, nuclear shrinkage, and pycnonuclei formation. In the current study, both Hoechst staining and comet assay confirmed that proportions of apoptotic cells dramatically increased in a dose-dependent manner upon MFKF-AP1β treatment compared with staurosporine or control cells ([Figs. 4 and 5](#f0020 f0025){ref-type="fig"}). Therefore, MFKF-AP1β can potentiate cytotoxicity by promoting apoptosis in cancer cells.

The ability of polysaccharides to induce apoptosis in cancer cells can differ greatly according to their chemical composition and configuration as well as their physical properties. Although it is difficult to correlate the structure and anti-tumor activity of complex polysaccharides, a relationship can be inferred. It has been suggested that structural features in the main chain of the glucan such as β-(1→3) linkages as well as β-(1→6) branch points are needed for anti-tumor activity ([@b0080; @b0030]). High molecular weight glucans appear to be more effective than low molecular weight species ([@b0095; @b0100; @b0105]). The polysaccharide used in the present study was a partially purified polysaccharide fraction with an average molecular weight of over 12 kDa. Its exact mechanism of action for activating apoptosis remains to be identified.

5. Conclusion {#s0095}
=============

In conclusion, our studies prove that MFKF-AP1β induces cell death in A549 lung carcinoma cells in a dose-dependent manner as well as apoptosis by elevation of LDH release, disruption of cellular morphology, and induction of nuclear damage. However, further investigation about the relationship between MFKF-AP1β-mediated cytotoxic and apoptotic pathways is needed.
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![Effect of MFKF-AP1β on viability of A549 lung cancer cells. The viability of cells pretreated with 1 μM staurosporine (positive control) and MFKF-AP1β at different concentrations (25, 50, and 100 μg/ml) for 24 h was estimated using MTT assay after being cultured for 24 h. Data are represented as the mean ± SD of three independent experiments. An asterisk indicates ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01, ^∗∗∗^*p* \< 0.001.](gr1){#f0005}

![Lactate dehydrogenase (LDH) release assay. There was a significant increase in LDH release from lung cancer cells as measured by colorimetric assay. Pretreatment with 1 μM staurosporine (positive control) and MFKF-AP1β at different concentrations (25, 50, and 100 μg/ml) for 24 h significantly increased LDH release from A549 cells as a measure of cytotoxicity. Data are represented as the mean ± SD of three independent experiments. An asterisk indicates ^∗∗^*p* \< 0.01.](gr2){#f0010}

![Morphological changes induced by (A) control, (B) 1 μM staurosporine, (C) 25 μg/ml of MFKF-AP1β, (D) 50 μg/ml of MFKF-AP1β, and (E) 100 μg/ml of MFKF-AP1β in A549 lung cancer cells after 24 h of treatment.](gr3){#f0015}

![Representative nuclear stained images of A549 cells following treatment with different concentrations of MFKF-AP1β (25, 50, and 100 μg/ml) and 1 μM staurosporine observed under a fluorescence microscope at a magnification of 40×. (A) Control; (B) treated with staurosporine; (C--E) MFKF-AP1β 25, 50, and 100 μg/ml, respectively.](gr4){#f0020}

![Representative Comet images of A549 cells following treatment with different concentrations of MFKF-AP1β (25, 50, and 100 μg/ml) and staurosporine (1 μM). (A) Control; (B) treated with staurosporine; (C--E) MFKF-AP1β (25, 50, and 100 μg/ml, respectively).](gr5){#f0025}

![Induction of cell death by MFKF-AP1β. A549 cells were treated with 1 μM staurosporine and MFKF-AP1β (25, 50, and 100 μg/ml), after which amount of single-stranded DNA was detected by an ApoStrand™ ELISA apoptosis detection kit. An asterisk indicates ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01.](gr6){#f0030}
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